RedHill Biopharma Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of RedHill Biopharma Ltd. generated cash of -$35,820,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,439,000 last year. Net change in cash is therefore -$14,399,000.
Cash Flow
| 2014 | -12.22M | -17.86M | 24.36M |
|---|---|---|---|
| 2015 | -17.82M | -21.19M | 54.79M |
| 2016 | -28.25M | 24.47M | 36.01M |
| 2017 | -44.76M | -18.58M | 25.65M |
| 2018 | -34.46M | 5.35M | 41.76M |
| 2019 | -40.74M | 5.16M | 35.50M |
| 2020 | -48.57M | -35.64M | 84.37M |
| 2021 | -65.04M | -8.14M | 73.46M |
| 2022 | -29.18M | 8.30M | 11.45M |
| 2023 | -35.82M | 4K | 21.43M |
RDHL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 19.96M | 29.47M | 29.29M | 29.02M | 29.00M | 16.45M | 53.78M | 21.51M | 5.89M | 11.85M |
Operating activities | ||||||||||
Net income | 23.91M | -71.66M | -97.74M | -76.17M | -42.30M | -38.82M | -45.54M | -29.37M | -21.09M | -10.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.99M | 8.15M | 18.14M | 8.74M | 1.21M | 90K | 81K | 44K | 36K | 27K |
Stock-based compensation expense | 1.64M | 5.67M | 10.21M | 4.20M | 3.02M | 0 | 2.23M | 1.67M | 1.36M | 1.75M |
| Deferred income tax benefit | 1.64M | 5.67M | 10.21M | 4.20M | 3.02M | 0 | 2.23M | 1.67M | 1.36M | 1.75M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 33.42M | -2.84M | -3.02M | -27.43M | -258K | 570K | -1.42M | 0 | 701.73K | 0 |
Inventories | 2.38M | 3.80M | -8.28M | -4.64M | -1.11M | -116K | -653K | 0 | 0 | 0 |
Accounts payable | -949.54K | -7.43M | 111K | 7.36M | 860K | -1.48M | 4.74M | -158K | 1.86M | -770K |
Cash generated by operating activities | -35.82M | -29.18M | -65.04M | -48.57M | -40.74M | -34.46M | -44.76M | -28.25M | -17.82M | -12.22M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -8.5M | 0 | -4.32M | -6.97M | -34.92M | -12.24M | -29.55M | -17M |
Investments In Property Plant And Equipment | -10.97K | -198K | -115K | -53.77M | -203K | -58K | -1.18M | -120K | -1.63M | -1.10M |
Acquisitions Net | 0 | 0 | 8.02M | 0 | 35K | 35K | 11.96M | -36.87M | 17.93M | 15.96M |
Cash generated by investing activities | 4K | 8.30M | -8.14M | -35.64M | 5.16M | 5.35M | -18.58M | 24.47M | -21.19M | -17.86M |
Financing activities | ||||||||||
Common Stock Issued | 13.95M | 23.80M | 78.53M | 23.86M | 36.3M | 41.90M | 22.21M | 35.75M | 54.68M | 19.36M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1.47M | -1.68M | -1.61M | -796K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 21.43M | 11.45M | 73.46M | 84.37M | 35.50M | 41.76M | 25.65M | 36.01M | 54.79M | 24.36M |
Net Change In Cash | -14.39M | -9.50M | 179K | 272K | 18K | 12.55M | -37.33M | 32.27M | 15.62M | -5.95M |
Cash at end of period | 5.56M | 19.96M | 29.47M | 29.29M | 29.02M | 29.00M | 16.45M | 53.78M | 21.51M | 5.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |